Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo.
about
Can heparins stimulate bone cancer stem cells and interfere with tumorigenesis?Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides.The antineoplastic effect of low-molecular-weight heparins - a literature reviewMultifunctional silk-heparin biomaterials for vascular tissue engineering applications.Effect of dalteparin, a low-molecular-weight heparin, as adjunctive therapy in patients with Kawasaki disease: a retrospective study.Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.Rat mesentery angiogenesis assay.Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?A systematic literature analysis of correlative studies in low-dose metronomic chemotherapy trials.von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans.Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.Comparative pharmacodynamic assessment of the antiangiogenesis activity of heparin and low-molecular-weight heparin fractions: structure-function relationship.Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets.
P2860
Q26852760-87F9C853-8F71-4CCA-903C-B4A647796263Q33928008-7F7FFB7B-3250-42F0-A26B-8AAB53ACD697Q36936771-15BFE060-F62C-47EA-8833-8E4C02F61E6FQ37414159-F6AEFE7F-C53B-4EA4-84FD-890A3CCDC188Q37541457-18A8A9A6-C29E-4C6B-8772-EECEF818B2B3Q37708829-7C7CB926-D15D-48D9-A919-33518E03407BQ37895454-E5F59B8D-CD42-4248-8EF4-439AB4C42BF7Q38155883-80812A8B-A1A9-44A2-8C6D-0A842BEFCEA0Q38249998-C378F816-EFF7-4696-B62B-C60E054A1893Q40671371-65436495-67B0-44D9-96C0-278BCFC1838DQ42554491-3C636113-A347-4644-8092-CB7A0F453165Q47326919-026CFB9A-EF77-42FD-A3E2-CC3829A1221AQ50317765-76ABC8B6-901F-4017-9FE2-513D681B73FC
P2860
Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Dalteparin, a low-molecular-we ...... eparin-binding VEGF-A in vivo.
@en
type
label
Dalteparin, a low-molecular-we ...... eparin-binding VEGF-A in vivo.
@en
prefLabel
Dalteparin, a low-molecular-we ...... eparin-binding VEGF-A in vivo.
@en
P2860
P1476
Dalteparin, a low-molecular-we ...... eparin-binding VEGF-A in vivo.
@en
P2093
Arvid Nordenhem
Klas Norrby
P2860
P304
P356
10.1111/J.1600-0463.2010.02635.X
P577
2010-10-12T00:00:00Z